Our top pick for
Beginners

HC2 Holdings Inc is a telecom services business based in the US. HC2 shares (HCHC) are listed on the NYSE and all prices are listed in US Dollars. HC2 employs 2,803 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
Latest market close | $4.28 |
---|---|
52-week range | $3.21 - $4.83 |
50-day moving average | $3.74 |
200-day moving average | $3.90 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.55 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.28 from 2021-11-19
1 week (2022-06-25) | N/A |
---|---|
1 month (2022-06-02) | N/A |
3 months (2022-04-02) | N/A |
6 months (2022-01-02) | N/A |
1 year (2021-07-06) | 6.47% |
---|---|
2 years (2020-07-06) | 37.62% |
3 years (2019-07-05) | 90.22% |
5 years (2017-07-05) | 5.83 |
Valuing HC2 stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HC2's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HC2's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $23.2 million.
The EBITDA is a measure of a HC2's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $1.1 billion |
---|---|
Operating margin TTM | 1.61% |
Gross profit TTM | $167.3 million |
Return on assets TTM | 0.16% |
Return on equity TTM | -21.3% |
Profit margin | -3.12% |
Book value | $6.27 |
Market capitalisation | $286.4 million |
TTM: trailing 12 months
We're not expecting HC2 to pay a dividend over the next 12 months.
HC2's shares were split on 27 August 2013.
Over the last 12 months, HC2's shares have ranged in value from as little as $3.21 up to $4.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while HC2's is 2.3046. This would suggest that HC2's shares are significantly more volatile than the average for this exchange and represent a higher risk.
HC2 Holdings, Inc. , through its subsidiaries, provides construction, insurance, life sciences, broadcasting, and other services in the United States, the United Kingdom, and internationally. The company models, details, fabricates, and erects structural steel for commercial and industrial, and infrastructure construction projects, including building and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants. It also fabricates trusses and girders; and fabricates and erects water pipes, water storage tanks, pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. In addition, the company provides equipment for the oil and gas industry. Further, it offers long-term care, life, annuity, and other accident and health coverage; focuses on developing products for early osteoarthritis of the knee, as well as skin lightening technology; and operates over-the-air broadcasting stations and Azteca America, a Spanish-language broadcast network. The company was formerly known as PTGi Holding Inc.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.